Sagen N, Nilsen S T, Kim H C, Koller O, Bergsjø P
Acta Obstet Gynecol Scand. 1984;63(7):603-8. doi: 10.3109/00016348409155545.
The prognostic value of total maternal plasma estriol, human placental lactogen (HPL) and hemoglobin (Hb) with regard to perinatal outcome was compared in 74 cases of severe pre-eclampsia. No combination of the tests predicted all cases of fetal and newborn pathology. HPL was the most reliable single test in cases of intra-uterine growth retardation, while Hb was the best predictor of severe fetal pathology and perinatal distress. In cases of severe fetal and neonatal pathology, the prognostic value of the combination of HPL and Hb was more reliable than the combination of all the three tests.
在74例重度子痫前期患者中，比较了母体血浆总雌三醇、人胎盘催乳素（HPL）和血红蛋白（Hb）对围产期结局的预后价值。这些检测指标的任何组合都不能预测所有胎儿和新生儿病变病例。对于宫内生长受限病例，HPL是最可靠的单项检测指标，而Hb是严重胎儿病变和围产期窘迫的最佳预测指标。在严重胎儿和新生儿病变病例中，HPL和Hb联合检测的预后价值比三项检测指标联合更可靠。
